Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added related topics: Prostate cancer and MedlinePlus Genetics to the page. This enhances access to disease- and genetics-related information without changing the core study details.
    Difference
    0.2%
    Check dated 2026-03-26T11:43:00.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. A related topics entry for Prostate cancer: MedlinePlus Genetics was removed (including its Revision: v3.4.3).
    Difference
    0.2%
    Check dated 2026-03-19T06:15:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added related topics Prostate cancer and MedlinePlus Genetics, and updated the site revision from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-12T02:33:58.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision label v3.4.2 has been added. The previously displayed government funding status notice (and the earlier v3.4.1 revision) has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T13:58:55.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A government funding notice banner was added, and the site revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:13:31.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated some metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with a new revision note 'Revision: v3.4.0'; the previous labels ('Last Update Submitted that met QC Criteria' and 'No FEAR Act data') and prior revision note 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:00:46.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.